Be the first to like this
Silence Therapeutics CEO Tomas Christély gave this presentation at the Proactive Investors One2One Forum in London, alongside ANGLE, Deltex Medical and Stanley Gibbons on 23rd November 2011.
Proactive Investors invited Silence Therapeutics to the event based on the biotech company's strong progression in the last few years, including a recent major partnership with a ‘Top 10’ pharmaceutical company and its confident development of valuable products such as the ATUPLEX delivery system.
For further information regarding investment opportunities with Silence or any other queries, please visit the contact us page on the Silence Therapeutics site or leave a comment on SlideShare: http://silence-therapeutics.com/content/contact/contactus.htm
Clipping is a handy way to collect important slides you want to go back to later.